RRPV Solicitation Summary: Rapid Antigen Production for Immunoassay Diagnostics (RAPID)
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Apr 15, 2026 |
| Due Date: | May 13, 2026 |
| Solicitation No: | RRPV-RPP-26-10-RAPID |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Apr 15, 2026 03:00 pm EDT
- Original Response Date: May 13, 2026 01:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: May 28, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) entitiled "Rapid Antigen Production for Immunoassay Diagnostics (RAPID)".
Through the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP, BARDA seeks to support advanced research and development of rapid antibody and other protein-based molecular recognition reagent generation platforms to enable timely production of immunoassay-ready reagents for diagnostic use. The objective is to establish flexible, end-to-end systems capable of generating high-performance binders against known and emerging biological threats, with the goal of significantly compressing development timelines from pathogen sequence to assay-ready reagents—ideally within weeks.
A Proposer’s Conference and Teaming Connect for the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP will take place virtually on Monday, April 27, 2026 from 11am-12pm EST.
The full RPP, how to register for the Conference, and information on joining the consortium can be accessed through the RRPV website - www.rrpv.org.
- O’NEILL HOUSE OFFICE BUILDING
- WASHINGTON , DC 20515
- USA
- Rebecca Harmon
- rebecca.harmon@ati.org
- Apr 15, 2026 03:00 pm EDTSpecial Notice (Original)
See Also
Follow CTN Data, Statistics, and Clinical Trial Support Center (DSC7) Active Contract Opportunity
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/30/2026
Follow CTN Data, Statistics, and Clinical Trial Support Center (DSC7) Active Contract Opportunity
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/30/2026
Follow FY25 Long Range Broad Agency Announcement (BAA) for Navy and Marine Corps
DEPT OF DEFENSE
Due by 9/30/2026
Follow FY26 NAWCAD Propulsion and Power Technology Development Program Broad Agency Announcement (BAA)
DEPT OF DEFENSE
Due by 9/30/2026